Feature | February 06, 2014

Photon-Counting Technique Increases Detection Rate in Screening Mammography

Mammography Systems Women's Health Clinical Study DR CR Radiation Dose

This shows two-view screening mammograms obtained with the DR photon-counting system show a spiculated mass in the right upper quadrants (arrow). The diagnosis was invasive ductal carcinoma, 8 mm in diameter, as seen on the (a) right craniocaudal image, (b) right mediolateral oblique image, and (c) zoomed in craniocaudal image of the lesion.

Mammography Systems Women's Health Clinical Study DR CR Radiation Dose

Two-view screening mammograms obtained with the DR photoncounting system show an indistinct mass in the left lower outer quadrant (arrow). The diagnosis was invasive ductal carcinoma, 7 mm in diameter, as seen on the (a) left craniocaudal image, (b) left mediolateral oblique image, and (c) zoomed in craniocaudal image of the lesion.

Mammography Systems Women's Health Clinical Study DR CR Radiation Dose

Two-view screening mammograms obtained with the DR photoncounting system show pleomorphic calcifications in a linear distribution in the right upper quadrants (arrow). The diagnosis was DCIS, as depicted on the (a) right craniocaudal image, (b) right mediolateral oblique image, and (c) zoomed in craniocaudal image of the lesion.

February 6, 2014 — Digital mammography screening with photon-counting technique offers high diagnostic performance, according to a study published online in the journal Radiology.
 
As mammography screening has shifted to digital technology, a range of computed radiography (CR) and direct radiography (DR) systems have emerged. The photon-counting technique is a DR approach that uses a detector to decrease scattered radiation and noise, enabling dose reduction.
 
"In population-based mammography screening, dose reducing techniques that don't compromise outcome parameters are desirable," said Walter Heindel, M.D., department of clinical radiology at the University Hospital Muenster in Muenster, Germany.
 
For the study, Heindel and colleagues analyzed data from the mammography screening program in North Rhine-Westphalia, the most populous state in Germany. They compared the screening performance of a DR photon-counting scan system with those of statewide operating screening units using different digital technologies. During the study period (2009 to 2010), 13,312 women were examined using the photon-counting system, and 993,822 women were screened with either CR or DR systems alone.
 
The DR photon-counting scan system had a cancer detection rate of 0.76 percent for subsequent screening, compared with 0.59 percent for the other screening units. The recall rate was 5.4 percent for the photon-counting method and 3.4 percent for the other methods.
 
"The higher cancer detection resulting from the use of the DR photon-counting scan system is due to high detection of both small, invasive cancers and ductal carcinoma in situ," Heindel said.
 
The photon-counting technique had almost twice the detection rate of other methods for ductal carcinoma in situ (DCIS), an early, noninvasive form of disease. It had a higher DCIS detection rate than the statewide units and the conventional DR subgroup.
 
In addition, the mean average glandular radiation dose of the DR photon-counting scan system was significantly lower than the conventional DR systems with the individually used parameters of the automatic exposure control.
 
The photon-counting technique also offers lateral dose modulation during the image acquisition, which can help account for differences in breast density. 
 
"One future research direction is the application of spectral imaging for quantification of breast glandular tissue, addressing the problem of breast density," Heindel said.
 
For more information: pubs.rsna.org/journal/radiology

Related Content

ASTRO, ASCO, SSO, guideline update, post-mastectomy radiotherapy, PMRT, radiation therapy
News | Radiation Therapy | September 23, 2016
September 23, 2016 — Three leading national cancer organizations issued a joint clinical practice guideline update fo
PET probes, breast cancer, surface receptor changes, MGH study, Memorial Sloan Kettering

After molecularly targeted therapy with an AKT inhibitor, the receptor tyrosine kinase (RTK) HER3 increases in this particular tumor, but the RTK EGFR does not. In this example, starting HER3 inhibitor therapy in addition to AKT inhibitor therapy is likely to be beneficial, but the addition of EGFR inhibitor therapy is not likely to be beneficial for treating this tumor. Image courtesy of Massachusetts General Hospital, Boston.

News | Nuclear Imaging | September 20, 2016
September 20, 2016 — Cancer biologists know that inhibitor-mediated feedback loop changes (increased expression of a
Digital Mammography DREAM Challenge, open-source competition, accuracy
News | Mammography | September 15, 2016
A coalition of oncology and technology partners led by Sage Bionetworks and DREAM Challenges last week announced the...
Are You Dense, E.M.P.O.W.E.R.E.D., Spanish, breast health, breast density, video
News | Breast Density | September 13, 2016
September 13, 2016 — Are You Dense Inc., in collaboration with Madre Latina Inc., recently announced a new set of edu
UCLA study, Oncotype Dx DCIS test, breast cancer, cost-effectiveness
News | Women's Health | September 13, 2016
A new study by a University of California Los Angeles (UCLA) researcher has found that a genomic test widely used to...
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
UCLA, chronic traumatic encephalopathy, CTE detection, MRI

Comparing a PET scan of an NFL player’s brain, left, and an MRI of a former high school football player’s brain shows similar suspected CTE pathology in the midbrain. Image courtesy of UCLA Health.

News | Neuro Imaging | September 12, 2016
September 12, 2016 — University of California Los Angeles (UCLA) doctors have found what may be an earlier and easier
Alzheimer's, ADNI3 study, Alzheimer's Disease Neuroimaging Initiative, NIH grant, MRI, PET, biomarkers
Feature | Neuro Imaging | September 09, 2016
September 9, 2016 — The Alzheimer’s Disease ...
mammography

MD Buyline Mammography Market Activity

Feature | Women's Health | September 07, 2016 | By Rachael Bennett, BHS, R.T.(R)(T) and Julie Johnson
Before the introduction of 3-D digital breast tomosynthesis (DBT) imaging, 2-D full field digital mammography (FFDM)...
ASTRO 2016 annual meeting, clinical trials and research, press program, radiation therapy
News | Radiation Therapy | September 07, 2016
The American Society for Radiation Oncology (ASTRO) announced the press program for its 58th Annual Meeting, Sept. 25-...
Overlay Init